Work

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehi877

Authors: Tomas Jernberg, Christopher D. Payne, Kenneth J. Winters, Christelle Darstein, John T. Brandt, Joseph A. Jakubowski, Hideo Naganuma, Agneta Siegbahn, Lars Wallentin

Institutions: Uppsala University Hospital, Eli Lilly (United States)

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2116457054

FWCI: 39.41

Cites: 22

Cited by: 534

Related to: 9